The Spectator

Which countries are most sceptical about vaccines?

Getty Images 
issue 28 November 2020

Gloss over

Should we be worried that the head of research into respiratory drugs at AstraZeneca is called Dr Pangalos, given that his near namesake, Dr Pangloss, is a byword for foolish optimism? Dr Pangloss was tutor to Candide in Voltaire’s satire on Gottfried Leibniz’s work on theodicy: the attempt to reconcile why a benevolent and all-powerful God should allow evil, tragedy — or a pandemic — to exist. Dr Pangloss’s favourite phrase, ‘all is for the best in the best of all possible worlds’, encapsulates Leibniz’s belief that the Earth, for all its apparent faults, was the best that God could possibly have created. Dr Pangloss’s belief collides with the horrible reality of the Lisbon earthquake, which occurred in 1755, four years before Candide was published. In spite of earning Voltaire’s derision, Leibniz played an important role in the evolution of scientific method, and would have appreciated AstraZeneca’s drug trials.

Calling the shots

Where are people most sceptical about vaccines? Percentage disagreeing with the general statement ‘vaccines are safe’:

MOST SCEPTICAL

France | 33%

Gabon | 26%

Russia | 24%

Switzerland | 22%

Armenia, Austria, Belgium, Iceland | 21%

Haiti | 20%

LEAST SCEPTICAL

Bangladesh, Egypt, Tajikistan | <1%

India, Laos, Rwanda, Tanzania | 2%

Ethiopia, Ghana, Lebanon, Malaysia, South Africa, Singapore, Thailand | 3%

The UK figure is 9% and the US is 11%.

Source: Wellcome Trust

Red alert

The Institute for Fiscal Studies expects public sector borrowing this year to reach £351 billion, or 17% of GDP. How does it compare with peaks of the past 60 years?

2009-10 | 10% GDP

1993-94 | 6.6%

1975-76 | 6.3%

1967-68 | 3.9%

1963-64 | 2.7%

Source: OBR

Making merry

Covid restrictions will be relaxed over Christmas. How many of us will celebrate?

— A 2016 YouGov poll found that 91% of the UK celebrate Christmas in some form.

Illustration Image

Disagree with half of it, enjoy reading all of it

TRY 3 MONTHS FOR $5
Our magazine articles are for subscribers only. Start your 3-month trial today for just $5 and subscribe to more than one view

Comments

Join the debate for just £1 a month

Be part of the conversation with other Spectator readers by getting your first three months for £3.

Already a subscriber? Log in